Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Myeloproliferative Disorders × Pharmaceutical Preparations × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 6 Neoplasms 3 Neoplasm Metastasis 3 Recurrence 2 Melanoma 2 Lymphoma, B-Cell, Marginal Zone 2 Head and Neck Neoplasms 2 Urinary Bladder Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Nephrotic Syndrome 1 Myeloproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Lymphoma 1 Locally Advanced Bladder Cancer 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Diseases 1 Hepatitis B 1 Gastrointestinal Diseases 1 Familial Mediterranean Fever 1 Esophageal Neoplasms 1 Depression 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1 Brain Neoplasms 1 Arthritis, Rheumatoid 1 Anxiety Disorders 1 Amyloidosis 1

Interventions

fludarabine phosphate 50 Cyclophosphamide 47 Peripheral Blood Stem Cell Transplantation 39 Mycophenolic Acid 32 Busulfan 31 Whole-Body Irradiation 28 Tacrolimus 27 Cyclosporine 27 Antilymphocyte Serum 27 Filgrastim 24 Methotrexate 19 Cytarabine 18 fludarabine 16 Etoposide 16 Radiotherapy 15 Melphalan 15 Methylprednisolone 12 ruxolitinib 11 thymoglobulin 8 Sirolimus 8 Psychiatric Rehabilitation 8 Flow Cytometry 8 Cyclosporins 8 Alemtuzumab 8 Granulocyte Colony-Stimulating Factor 7 Decitabine 7 Cord Blood Stem Cell Transplantation 7 Azacitidine 7 Daunorubicin 6 sargramostim 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04994158 2025-07-30

MASCOT-R

Royal Free Hospital NHS Foundation Trust

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡